ArticleCancer cell international2021

SHP2 inhibition enhances the anticancer effect of Osimertinib in EGFR T790M mutant lung adenocarcinoma by blocking CXCL8 loop mediated stemness.

Leiming Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.